(NASDAQ: ANL) Adlai Nortye's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 6.42%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 61.68%.
Adlai Nortye's earnings in 2025 is -$51,869,000.On average, 1 Wall Street analyst forecast ANL's earnings for 2025 to be -$39,852,289, with the lowest ANL earnings forecast at -$39,852,289, and the highest ANL earnings forecast at -$39,852,289.
In 2026, ANL is forecast to generate -$39,852,289 in earnings, with the lowest earnings forecast at -$39,852,289 and the highest earnings forecast at -$39,852,289.